Nektar Investors Face May 5 Deadline in Securities Suit Over REZOLVE-AA Trial Claims

Overview

• Rosen Law Firm, The Schall Law Firm, and DJS Law Group are urging Nektar shareholders to seek the lead-plaintiff role before the May 5, 2026 deadline.
• The filed complaint says the REZOLVE-AA trial for rezpegaldesleukin did not follow enrollment and protocol standards, which likely hurt the study’s results.
• Plaintiffs allege Nektar overstated the trial’s integrity and prospects, making public statements false or misleading during February 26 to December 15, 2025.
• The notices state that no class has been certified and that investors are not represented unless they retain counsel, though they can still share in any future recovery.
• A lead plaintiff is an investor who represents the group in court and helps choose the lawyers and strategy for the case.